What Eagle Health Investments LP reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 1842545 · Filed Aug 10, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 308.1K |
| −14.0% |
| $53.5M |
| 8.9% |
GHGuardant Health, Inc. | 300.7K | −3.1% | $45.1M | 7.5% |
INSMINSMED Inc | 384.1K | +71.3% | $41M | 6.8% |
BMRNBioMarin Pharmaceutical Inc | 624.7K | +23.5% | $35.7M | 5.9% |
ILMNIllumina, Inc. | 187.4K | ±0% | $33M | 5.5% |
SRRKScholar Rock Holding Corp | 555.3K | +12.4% | $30.5M | 5.1% |
PTGXProtagonist Therapeutics, Inc | 248.3K | +38.5% | $30.4M | 5% |
RAREUltragenyx Pharmaceutical Inc. | 884.1K | ±0% | $29.5M | 4.9% |
CMPSCOMPASS Pathways plc | 2.1M | ±0% | $29.2M | 4.8% |
ASNDAscendis Pharma A/S | 106.2K | New | $28.3M | 4.7% |
RVMDRevolution Medicines, Inc. | 120.3K | +0.7% | $22.5M | 3.7% |
FTREFortrea Holdings Inc. | 1.2M | −9.7% | $20.6M | 3.4% |
KYMRKymera Therapeutics, Inc. | 166.1K | +13.9% | $19.1M | 3.2% |
AXSMAxsome Therapeutics, Inc. | 65.1K | New | $15.9M | 2.6% |
BSXBoston Scientific Corp | 369.2K | +25.9% | $15.8M | 2.6% |
ALKSAlkermes plc. | 297.3K | +24.6% | $15.6M | 2.6% |
IONSIonis Pharmaceuticals Inc | 194.6K | New | $15.4M | 2.6% |
TEMTempus AI, Inc. | 256.3K | ±0% | $14.8M | 2.5% |
DNTHDianthus Therapeutics, Inc. | 131.3K | New | $12.8M | 2.1% |
ATAIAtaiBeckley Inc. | 1.7M | ±0% | $9M | 1.5% |
AVTXAvalo Therapeutics, Inc. | 235.1K | New | $4.3M | 0.7% |
NTRANatera, Inc. | 15.8K | −87.0% | $4.3M | 0.7% |
LLYELI LILLY & Co | 2K | New | $2.4M | 0.4% |
ISRGIntuitive Surgical Inc | 4.4K | ±0% | $1.7M | 0.3% |
IMCRImmunocore Holdings plc | 46.3K | ±0% | $1.5M | 0.2% |
PCSCFreenome, Inc. | 37.7K | ±0% | $410K | 0.1% |
